Therabot

March 28 - Technology media outlet newatlas published a blog post yesterday (March 27) reporting that Therabot, a generative AI chatbot developed at Dartmouth College, has shined in the first randomized clinical trial for mental health issues. 106 U.S. participants with major depressive disorder (MDD), generalized anxiety disorder (GAD), or eating disorders experienced an average reduction of 511 TP3T in depressive symptoms, a reduction of 311 TP3T in anxiety symptoms, and an improvement of 191 TP3T in body image perceptions in people with eating disorders after four weeks of use with the bot.The research team...